Afaf Tawfiq, M.D., Abdul-Fattah Agameya, M.D., Paul Claman, M.D.

Slides:

Advertisements

Similar presentations

Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes

Advertisements

Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment Talia Eldar-Geva, M.D.,

Antagonists in poor-responder patients

A case of a methotrexate-resistant ectopic pregnancy in which dactinomycin was effective as a second-line chemotherapy Satoe Fujioka, M.D., Yoshiki Yamashita,

Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during.

Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage

Ratio between inner cell mass diameter and blastocyst diameter is correlated with successful pregnancy outcomes of single blastocyst transfers Miriam.

Soyoung Bae, M.D., Joseph Karnitis, M.D. Fertility and Sterility

Evaluation of basal estradiol levels in assisted reproductive technology cycles2 John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,

Joël Coste, M. D. , Ph. D. , Jean Bouyer, Ph. D

Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy David Soriano, M.D., Danielle.

Conservative management of cervical ectopic pregnancy

Isabel Cerveira, M. D. , Cristina Costa, M. D. , Fernando Santos, M. D

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy Ewa Nowak-Markwitz,

Medical treatment of ectopic pregnancy: a committee opinion

Aviad Cohen, M.D., Benny Almog, M.D., Togas Tulandi, M.D., M.H.C.M.

Embryo transfer: techniques and variables affecting success

The impact of total gonadotropin dose on spontaneous abortion rates and early pregnancy outcomes in infertile couples undergoing gonadotropin induction/intrauterine.

Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies Gillian Homan, Susan Brown, R.N., John Moran,

Kimberly Elford, M.D., Paul Claman, M.D. Fertility and Sterility

Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy Beata E. Seeber, M.D., Mary D.

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M

Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review Seema Menon, M.D., John.

Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver Survey T. Ted Song, DO, Duncan Brown, PhD, Martin Karjalainen, MD, Ulrike.

Are serum human chorionic gonadotropin clearance curves of use in monitoring methotrexate treatment in cervical pregnancy? Petra J. Hajenius, M.D., Daphne.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Life-table analysis of the success of thermal balloon endometrial ablation in the treatment of menorrhagia Ingrid Hung Lok, M.B.B.S., B.Sc.(Med), M.R.C.O.G.,

Mark D Hornstein, M. D. , Owen K Davis, M. D. , Joe B Massey, M. D

The postwash total progressively motile sperm cell count is a reliable predictor of total fertilization failure during in vitro fertilization treatment

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

From partner's desk to iPad

Mark A. Zakaria, M. D. , Mazen E. Abdallah, M. D. , Valerie I

Severe intra-abdominal bleeding from neglected omental implantation of ectopic tissue after methotrexate treatment for persistent ectopic pregnancy Mei-Chu.

Use of “2-dose” regimen of methotrexate to treat ectopic pregnancy

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Reproductive outcome after laparoscopic instillation of hyperosmolar glucose into unruptured tubal pregnancies Albrecht Giuliani, M.D., Werner Hoenigl,

Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.

Marianne de Bennetot, M. D. , Benoît Rabischong, M. D. , Ph. D

Clarisa R Gracia, M. D. , Hillary A Brown, M. D. , Kurt T Barnhart, M

Effect of treatment of a previous ectopic pregnancy on in vitro fertilization– intracytoplasmic sperm injection outcomes: a retrospective cohort study

“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss Michelle.

David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Regulation of assisted reproductive technologies in the United States

Hassan N Sallam, M.D., Ph.D., F.R.C.O.G., Sameh S Sadek, M.D.

Effect of endometriosis on in vitro fertilization

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Peripheral natural killer cell activity as a predictor of recurrent pregnancy loss: a large cohort study Kinue Katano, M.D., Sadao Suzuki, M.D., Yasuhiko.

Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization Amihai Barash, M.D., Nava.

Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization David W. Schmidt, M.D.,,

Is tubal embryo transfer of any value

L. M. Cookingham, E. H. Duran, R. P. Goossen, D. K. Shah, A. Sparks, B

Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows Jessica.

Marcia A Ellison, PhD, Janet E Hall, MD Fertility and Sterility

M. Rafet Gazvani, Michelle Bates, Gillian Vince, Ph. D

Luteal phase support Fertility and Sterility

Jeffrey M Goldberg, M. D. , Edward Mascha, M. S. , Tommaso Falcone, M

Combined use of uterine artery embolization and local methotrexate injection in interstitial ectopic pregnancies with poor prognosis Gemma Tamarit, M.D.,

Bárbara Oriol, M. D. , Ana Barrio, M. D. , Alberto Pacheco, Ph. D

Predictive factors of failure in management of ectopic pregnancy with single-dose methotrexate: a general population-based analysis from the Auvergne.

Early pregnancy loss in in vitro fertilization (IVF) is a positive predictor of subsequent IVF success G.Wright Bates, M.D., Elizabeth S Ginsburg, M.D.

Peter M. Martin, M.D., H.Gilbert Welch, M.D. Fertility and Sterility

An alternative treatment option in tubal ectopic pregnancies with fetal heartbeat: aspiration of the embryo followed by single-dose methotrexate administration

Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of.

Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate Pythia T Nieuwkerk,

Hulusi B Zeyneloglu, M.D., Aydin Arici, M.D., David L Olive, M.D.

Ernesto Bosch, M. D. , Elena Labarta, M. D

Presentation transcript:

Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate Afaf Tawfiq, M.D., Abdul-Fattah Agameya, M.D., Paul Claman, M.D. Fertility and Sterility Volume 74, Issue 5, Pages 877-880 (November 2000) DOI: 10.1016/S0015-0282(00)01547-8

Figure 1 Outcome of EP patients treated with MTX. Tawfiq. Methotrexate and ectopic pregnancy. Fertil Steril 2000. Fertility and Sterility 2000 74, 877-880DOI: (10.1016/S0015-0282(00)01547-8)

Figure 2 Adjusted odds ratios for variables that affect risk of MTX treatment failure, using multivariate analysis. Tawfiq. Methotrexate and ectopic pregnancy. Fertil Steril 2000. Fertility and Sterility 2000 74, 877-880DOI: (10.1016/S0015-0282(00)01547-8)